Low impact
The post discusses Vertex's lead in non-opioid pain drugs and Eli Lilly's large spending to catch up, with implications for both stocks.
Finnhub06/20, 01:20 PM
Related assets
Coming up for VRTX
Explore next
Latest VRTX news
Finnhub07/14, 01:47 AM
Vertex Pharmaceuticals announced its largest-ever acquisition, Crinetics Pharmaceuticals.
Finnhub07/10, 03:25 PM
Finnhub07/10, 12:29 AM